Europe Transfection Technologies Market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, and Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Country 2024-2032

Europe Transfection Technologies Market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, and Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A4242
Buy Now

Market Overview:

The Europe transfection technologies market size reached US$ 339.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 715.2 Billion by 2032, exhibiting a growth rate (CAGR) of 8.37% during 2024-2032. The growing prevalence of cancer and cardiovascular diseases (CVDs) among individuals, increasing demand for better therapeutics across different European countries, and the rising expenditure on clinical research represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023 US$ 339.5 Billion
Market Forecast in 2032 US$ 715.2 Billion
Market Growth Rate 2024-2032 8.37%


Transfection refers to a method of introducing nucleic acids, such as oligonucleotides, ribonucleic acid (RNA), and deoxyribonucleic acid (DNA), into eukaryotic cells. It comprises various methods, such as lipofection, electroporation, nucleofection, cationic lipid transfection, and in-vivo transfection, to modify properties of a cell. It focuses on altering the host genome to express or block the expression of the protein associated with the gene. It can efficiently treat incurable and inherited genetic diseases, such as albinism, apert syndrome, cystic fibrosis (CF), and down syndrome, among individuals. It assists in enabling the study of a gene function or gene products by improving specific gene expression in cells and making recombinant proteins in mammalian cells. It aids in gene silencing and producing stable cell lines and offers high transition efficiency with low cell toxicity. As it is widely employed for target validation, bio-medical research, and therapeutic delivery, the demand for transfection technologies is increasing in Europe.

Europe Transfection Technologies Market Trends:

At present, the rising prevalence of cancers and various cardiovascular diseases, such as stroke, coronary heart disease, aortic disease, and peripheral arterial diseases, among individuals represents one of the key factors supporting the growth of the market in Europe. Besides this, the growing demand for transfection technologies due to the increasing number of obese people is positively influencing the market in the region. In addition, the escalating demand for better therapeutics among the masses, along with the rising focus on the development of cell-based therapies, is propelling the growth of the market. Apart from this, the increasing adoption of reagent-based transfection technology, as it is cost-effective and less complicated compared to other methods, is contributing to the market growth. Moreover, governing agencies in different countries of Europe are encouraging the utilization of transfection technologies by providing funds for research and development. Additionally, the increasing expenditure on clinical research due to the concern for human health is offering lucrative growth opportunities to industry investors operating in the region. In line with this, the rising demand for new transfection technologies to address various needs for therapeutic delivery is bolstering the growth of the market. Furthermore, key players are introducing viral vector transfection kits for cell and gene therapy manufacture, which is strengthening the growth of the market in Europe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe transfection technologies market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on product type, application, transfection method, technology and end user.

Product Type Insights:

  • Reagent
  • Instrument
  • Others
     

The report has provided a detailed breakup and analysis of the Europe transfection technologies market based on the product type. This includes reagent, instrument, and others. According to the report, reagent represented the largest segment.

Application Insights:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others
     

A detailed breakup and analysis of the Europe transfection technologies market based on the application has also been provided in the report. This includes therapeutic delivery, bio-medical research, protein production, and others. According to the report, bio-medical research accounted for the largest market share.

Transfection Method Insights:

  • Lipofection
  • Electroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others
     

A detailed breakup and analysis of the Europe transfection technologies market based on the transfection method has also been provided in the report. This includes lipofection, electroporation, nucleofection, cotransfection, cationic lipid transfection, in-vivo transfection, and others. According to the report, electroporation accounted for the largest market share.

Technology Insights:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection
     

A detailed breakup and analysis of the Europe transfection technologies market based on the technology has also been provided in the report. This includes physical transfection, biochemical based transfection, and viral-vector based transfection. According to the report, biochemical based transfection accounted for the largest market share.

End User Insights:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others
     

A detailed breakup and analysis of the Europe transfection technologies market based on the end user has also been provided in the report. This includes research centers and academic institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.

Country Insights:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Germany, France, the United Kingdom, Italy, Spain, and others. According to the report, Germany companies accounted for the largest market share.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the Europe transfection technologies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. For each of the companies covered, the report provides business overview, services offered, business strategies, financials, SWOT analysis, and major news and events.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product Type, Application, Transfection Method, Technology, End User, Country
Countries Covered Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Europe transfection technologies market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the Europe transfection technologies market.
  • The study maps the leading, as well as the fastest-growing, regional markets.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Europe transfection technologies industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

The Europe transfection technologies market was valued at US$ 339.5 Billion in 2023.

We expect the Europe transfection technologies market to exhibit a CAGR of 8.37% during 2024-2032.

The increasing prevalence of cancer and various chronic lifestyle diseases, along with the rising utilization of advanced transfection technologies in drug discovery, target validation, and cellular research, is primarily driving the Europe transfection technologies market.

The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of transfection technologies for the development of novel vaccines and therapeutic drugs to combat the risk of the coronavirus infection across several European nations.

Based on the product type, the Europe transfection technologies market can be segmented into reagent, instrument, and others. Currently, reagent holds the majority of the total market share.

Based on the application, the Europe transfection technologies market has been divided into therapeutic delivery, bio-medical research, protein production, and others. Among these, bio-medical research currently exhibits a clear dominance in the market.

Based on the transfection method, the Europe transfection technologies market can be categorized into lipofection, electroporation, nucleofection, cotransfection, cationic lipid transfection, in-vivo transfection, and others. Currently, electroporation accounts for the largest market share.

Based on the technology, the Europe transfection technologies market has been segregated into physical transfection, biochemical based transfection, and viral-vector based transfection, where biochemical based transfection currently exhibits a clear dominance in the market.

Based on the end user, the Europe transfection technologies market can be bifurcated into research centers and academic institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others. Currently, pharmaceutical and biotechnology companies hold the majority of the total market share.

On a regional level, the market has been classified into Germany, France, United Kingdom, Italy, Spain, and others, where Germany currently dominates the Europe transfection technologies market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Europe Transfection Technologies Market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, and Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Country 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More